Statins in the Management of Pediatric Dyslipidemia

详细信息    查看全文

• 作者：Joyce L. Ross ; MSN ; ANP ; CS ; CRNP ; FNLA ; FPCNA ; ^{jlr@joycerossnp.com}
• 关键词：Children ; Dyslipidemia ; Familial hypercholesterolemia ; HMG-CoA reductase ; Pediatrics ; Statins
• 刊名：Journal of Pediatric Nursing
• 出版年：2016
• 出版时间：November-December 2016
• 年：2016
• 卷：31
• 期：6
• 页码：723-735
• 全文大小：552 K
• 卷排序：31

文摘

About 20% of children have dyslipidemia; most are underdiagnosed and undertreated. FH is a treatable genetic condition that causes lifelong elevations in LDL-C. Early diagnosis and appropriate management of dyslipidemia can reduce CVD risk. Statins improve the lipid profile in children with HeFH. Statins are well tolerated, with similar side-effect profiles in children and adults.